This page shows what was measured, who it was measured in, and what that does not settle.
What Albumin does in the body
And children
From the FDA-approved label: Human albumin accounts for more than half of the total protein in the plasma and represents about 10% of protein synthesis activity by the liver. Human Albumin 25% has a corresponding hyperoncotic effect. The primary physiological function of albumin results from its contribution to plasma colloid oncotic pressure and transport function. Albumin stabilizes circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins. Other physiological functions include antioxidant properties, free radical scavenging, and capillary membrane integrity.
What happened in people
RNAWiki has not yet published a reviewed conclusion for this use.
§ A fixed RNAWiki sentence
Where this came from
Wording RNAWiki always uses, not a finding about this substance.
No reviewed claim names a result for any goal on this record.
No source is stored against this line.
The limit that matters most
Not recorded.
Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
RNAWiki has not recorded a supervision or regulatory status for this substance.
What the registries record it as
The substance registry classes this as structurallydiverse.
FDA substance registry · ZIF514RVZR · read 2026-08-29
It is recorded as coming from CRYOPOOR PLASMA. The part recorded is blood.
FDA substance registry · ZIF514RVZR · read 2026-08-29
Where each sentence above came from
No recorded sentence describes the change this makes in a way that stands on its own. The page opens with what it is taken for instead, and the recorded explanation follows below.
Shown as the opening line on this page.
No statement of the main limit is recorded.
The four opening statements run to 99 words.
Words this page uses
Four words worth knowing first
Chosen from what this page shows, with each one explained before the word it depends on.
Biomarker
A biomarker is a number from a test that stands in for something about health.
A picture of it, and where the picture fails
A biomarker is like a fuel gauge.
Where that stops being true. A gauge is wired to the tank. Many biomarkers are only loosely tied to health.
What people get wrong. A better number is read as a better life. Several medicines improved a number and helped nobody.
A measurable indicator used as a substitute for a clinical outcome of interest.
Placebo
A placebo is a dummy treatment given so the real one can be compared with it.
A picture of it, and where the picture fails
A placebo is like a blank control in an experiment.
Where that stops being true. A blank does nothing. People given a placebo often do get better.
What people get wrong. A placebo effect is read as imaginary. The improvement is measured and real.
An inactive intervention matched in appearance to the test intervention, used to control for non-specific effects.
Comparator
A comparator is whatever the treatment was measured against.
A picture of it, and where the picture fails
It is like the other runner in a race.
Where that stops being true. A race has one winner. A study can show both arms improved.
What people get wrong. Results are read without asking what the other group got. Beating nothing is not beating a treatment.
The control condition against which the experimental intervention is assessed.
What happened in people◇Read from sources, not yet reviewed
What happened in people
Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.
Proportion of ICU admissions receiving albumin
✗ The study did not show it
Who was studied
NCT04187534
How many people
50000
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Injection
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
FDA label (openFDA SPL) · a recorded source, not a stored snapshot
Number of Participants With First Occurrence of Any Component of Composite MACE (CV Death, MI, or Stroke)
✗ The study did not show it
Who was studied
NCT03473223
How many people
18226
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
Living longer, or avoiding a major event
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Injection
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
FDA label (openFDA SPL) · a recorded source, not a stored snapshot
The First 3-point Major Adverse Cardiovascular Events (3P-MACE)
✗ The study did not show it
Who was studied
NCT01243424
How many people
6103
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Injection
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
FDA label (openFDA SPL) · a recorded source, not a stored snapshot
Percentage of Participants Experiencing an Adverse Event (AE) After ProQuad® Dose 2
✗ The study did not show it
Who was studied
NCT00560755
How many people
3388
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Injection
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
FDA label (openFDA SPL) · a recorded source, not a stored snapshot
Change from Baseline on the log scale in high-sensitivity C-reactive protein (hs-CRP)(Phase 2b)
✗ The study did not show it
Who was studied
NCT05485961
How many people
3110
Study design
Phase 2/Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Injection
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
FDA label (openFDA SPL) · a recorded source, not a stored snapshot
Percentage of Participants With Adjudicated Primary Composite Joint Safety Outcome
✗ The study did not show it
Who was studied
NCT02528188
How many people
3021
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated
What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.
The limits of this study, and where it came from
Main limit. No limitation is recorded for this study.
How far it carries. This study is recorded from the curated record, not from the registry match.
Form and route. Injection
Interval reported. Not recorded in this summary
Written into the record, not signed off as a reviewed claim.
openFDA Drugs@FDA · a recorded source, not a stored snapshot
openFDA NDC Directory · a recorded source, not a stored snapshot
openFDA SPL label · a recorded source, not a stored snapshot
FDA label (openFDA SPL) · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.
What is missing or unclear◇Read from sources, not yet reviewed
Were people like you studied?
RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.
Who was studied
People similar to this profile were included.
ALBUMINEX 25% is a 25% albumin solution indicated for adults and children: Hypovolemia ( 1.1 ) Ascites ( 1.2 ) Hypoalbuminemia including from burns ( 1.3 ) Acute Nephrosis ( 1.4 ) Acute Respiratory Distress Syndrome (ARDS) ( 1.5 ) Cardiopulmonary Bypass ( 1.6 ) 1.1 Hypovolemia ALBUMINEX 25% is indicated for restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use…
Who is missing from the studies
Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
What the label states about particular groups
On people who are pregnant, the label states: “Risk Summary There are no data with ALBUMINEX 25% use in pregnant women to inform on drug-associated risk.”
US prescribing information · 167f48d0-8ae5-4f7e-b050-9673dad78acc · read 2026-08-30
On people who are breastfeeding, the label states: “Risk Summary There is no information regarding the presence of ALBUMINEX 25% in human milk, the effects on the breast-fed infant, or the effects on milk production.”
US prescribing information · 167f48d0-8ae5-4f7e-b050-9673dad78acc · read 2026-08-30
Where the result stopped carrying
This is a scope explorer, not a diagnosis engine.
It shows who was studied so you can see whether people similar to you were included.
RNAWiki cannot tell whether a study fits you. It can show who was in it.
What it would be like to take◇Read from sources, not yet reviewed
Why it might seem to do nothing
A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.
It was studied in different people
The people in the studies were not much like the reader.
On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
The evidence may simply be wrong
Small early studies often do not hold up.
On this record: RNAWiki has not yet published a reviewed conclusion for this use.
Other reasons RNAWiki checked and found nothing for (11)
It was studied for a different goal
The studies measured something else entirely. Nothing in this record points to this reason.
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.
None of these is a reason to take more. Taking more is not a step this page ever suggests.
What it would be like to take◇Read from sources, not yet reviewed
What taking it involves
The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.
How it is supplied
Prescription only
❝ Quoted from a source
Where this came from
Copied from a source RNAWiki stored, with the source named.
Read from the recorded approval status.
No source is stored against this line.
Form and route
Injection
✎ Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
The form and route recorded on this substance.
No source is stored against this line.
Who oversees it
RNAWiki has not recorded a supervision or regulatory status for this substance.
❝ Quoted from a source
Where this came from
Copied from a source RNAWiki stored, with the source named.
No register row and no identity class settled the question.
No source is stored against this line.
What is in the pack
Sold as injectable, injection, solution, solution, liquid, given by the injection, intravenous, oral route.
✎ Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
Recorded notes on how this is sold and what that means for what is in the pack.
No source is stored against this line.
Where it is registered
Regulatory records are listed in the technical disclosure at the foot of this page.
# Counted from records
Where this came from
A count of rows RNAWiki holds. It describes our records, not your body.
Register entries are stored per jurisdiction and shown with their dates.
No source is stored against this line.
Why people stop
Not recorded.
∅ Nothing recorded
Where this came from
RNAWiki holds nothing here and says so rather than guessing.
No record of why people stopped taking it is stored for this substance.
No source is stored against this line.
What it would be like to take∅Nothing found in the sources checked
What can go wrong
Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.
∅Nothing found in the sources checked
No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.
The sources listed were searched and held nothing. That is not the same as nothing existing.
Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.
Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
What is missing or unclear◇Read from sources, not yet reviewed
Does the exact form matter?
Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.
The form that was studied
Injection
✎ Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
The form used in the studies cited on this page.
No source is stored against this line.
What is sold
Not recorded.
∅ Nothing recorded
Where this came from
RNAWiki holds nothing here and says so rather than guessing.
Nothing further is recorded about which forms are sold.
No source is stored against this line.
What is recorded as being sold
26 products list this as an active ingredient in the United States drug directory. 25 of them contain it and nothing else.
FDA National Drug Code directory · 68516-5215 · read 2026-08-29
They are sold as injection, solution, liquid and solution, taken intravenous and oral.
FDA National Drug Code directory · 68516-5215 · read 2026-08-29
The regulator's established pharmacologic class for it is human serum albumin [epc], increased intravascular volume [pe] and increased oncotic pressure [pe].
FDA National Drug Code directory · 68516-5215 · read 2026-08-29
3 published labels name it as an active ingredient. 2 of them describe this substance alone, which is where its own label text on this page comes from.
US prescribing information · 167f48d0-8ae5-4f7e-b050-9673dad78acc · read 2026-08-29
Those labels are classed as human otc drug and human prescription drug.
US prescribing information · 167f48d0-8ae5-4f7e-b050-9673dad78acc · read 2026-08-29
2462 marketed supplement labels list this ingredient, classed as amino acid/protein, other combinations and vitamin.
Those labels carry all other, nutrient and structure/function claims. A claim of that kind is written by the manufacturer and is not assessed by any regulator, so its presence says nothing about whether it is true.
ALBUMINEX is intravenous at 3 DOSAGE FORMS AND STRENGTHS ALBUMINEX 25% is a sterile, aqueous solution of human albumin (25% w/v i.e. 25 g/dL) for intravenous administration available as: 50 mL (12.5 g) single dose vial 100 mL (25 g) single dose vi…, recorded as fda label in effect 2024-12-31 in the United States.
US prescribing information · 167f48d0-8ae5-4f7e-b050-9673dad78acc · read 2026-08-30
Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.
What it would be like to take◇Read from sources, not yet reviewed
What you could measure
This one is decided with a clinician, so this section holds questions to ask rather than a plan to run.
RNAWiki could not confidently classify this substance, so no self-experiment plan is offered.
Questions worth asking
Which of the trials of Albumin studied people like me?
What was measured, and for how long?
Was the result a laboratory value or a health outcome?
What would we watch for, and when would we stop?
Tracking can show whether something changed for you. It cannot show what caused it.
RNAWiki records evidence. It does not say whether this substance is right for you.
What is missing or unclear◇Read from sources, not yet reviewed
What nobody knows yet
Open questions, each with why it is open and what would close it.
Missing populations
Which groups were under-represented in the studies has not been recorded.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Missing long-term data
No completed tested study window is recorded.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
No reviewed conclusion
RNAWiki has not yet published a reviewed conclusion for this use.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Missing interaction studies
No interaction was found in the registers checked. Not finding one is not the same as showing there is none.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Formulation uncertainty
Several salts, forms or products of Albumin are recorded. Results from one form may not transfer to another.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Mechanism not reviewed
No reviewed mechanism story exists for this substance.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
What happened in people◇Read from sources, not yet reviewed
Check any of this yourself
Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.
Where else this substance is registered
FDA substance identifier (UNII)
ZIF514RVZR
RxNorm concept
2054168
Checks this page had to pass
✓ Passed
Identity resolved
no open identity hold
✓ Passed
No unresolved merge across substance families
no quarantine open
✓ Passed
Every public sentence names a source
The opening statement carries the origin: Written into the record, not signed off.
✗ Not passed
Trial roles classified for highlighted evidence
No registered study is classified as testing this substance.
✓ Passed
No internal keys in reader text
enforced by the copy-contract test over the rendered page
✗ Not passed
Safety mode resolved
No register row and no identity class settled the question.
✓ Passed
Canonical metadata present
slug and display name present
What is missing or unclear◇Read from sources, not yet reviewed
How this medicine reached us
Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.
What the approval register records
1 approved application covers products containing this substance. The earliest was NDA020899, approved 19971231 to GE HEALTHCARE.
This order is fixed in code and does not count clicks or time on the page.
What is not here
9 questions this page could not answer
These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.
What was measured, goal by goal — found nothing in the sources checked.
How close this is to real life — found nothing in the sources checked.
The path through the body — found nothing in the sources checked.
Felt, measured, or meaningful — found nothing in the sources checked.
How long anything takes — found nothing in the sources checked.
What it may clash with — found nothing in the sources checked.
Other ways to the same goal — found nothing in the sources checked.
Claims that go past the evidence — found nothing in the sources checked.
What changed on this page — found nothing in the sources checked.
The record as stored
The full record, for auditing
Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.
Recorded evidence blocks (8)
Q1
On the Albumin label: indicated for what?
"ALBUMINEX 25% is a 25% albumin solution indicated for adults and children : Hypovolemia ( 1.1 ) Ascites ( 1.2 ) Hypoalbuminemia including from burns ( 1.3 ) Acute Nephrosis ( 1.4 ) Acute Respiratory Distress Syndrome (ARDS) ( 1.5 ) Cardiopulmonary Bypass ( 1.6 ) 1.1 Hypovolemia ALBUMINEX 25% is indicated for…": indications and usage on Albumin's label. DailyMed label · 167f48d0-8ae5-4f7e-b050-9673dad78acc · 2024-12-31
Q2
127 registered trials of Albumin — at which phases?
Registered studies posting no result
112 of 127
127 registered studies of Albumin: 36 na, 31 phase2, 26 phase3, 26 phase4, 8 na or unstated, 8 phase1, 1 early phase1. CLINICALTRIALS_SNAPSHOT · 2026-09-01
8547 with a PubMed record
Show the evidence
na
36
phase2
31
phase3
26
phase4
26
na or unstated
8
phase1
8
8 more recorded rows
early phase1
1
completed
66
unknown
18
recruiting
13
terminated
11
withdrawn
11
not yet recruiting
7
active not recruiting
1
recorded 2026-09-01 · last checked 2026-09-04
Q3
22 of Albumin's trials stopped: safety, futility/efficacy, accrual/recruitment, funding/business, other?
safety (3), futility/efficacy (1), accrual/recruitment (6), funding/business (4) and other (8): Albumin's stop wording, clustered. CLINICALTRIALS_SNAPSHOT · 2026-09-01
"Recruitment halted by DSMB following interim analysis."; 22 of 127 registered studies
Show the evidence
Trial
NCT00235495
terminated; "Recruitment halted by DSMB following interim analysis."
NCT00570960
terminated; "drug product became unavilable"
NCT00990509
terminated; "Enrollment was stopped due to low recruitment and the PI's move to a different institution."
NCT01359813
terminated; "decision of independent monitoring committee:Risk of death at 3 months higher in Albumin group than in control group, without reaching significance level."
NCT01587222
withdrawn; "the sponsor did not provide the treatment"
NCT01747408
terminated; "The study met the pre-specified criteria for stopping the trial"
14 further recorded trials
NCT01849757
withdrawn; "Pentaspan is no longer used at our institution. Pentaspan was an arm of the study"
NCT01867645
terminated; "The trial was terminated early due to futility in reaching the primary endpoint."
NCT02034279
terminated; "Low recruitment rate and expiration of the study drug"
NCT02448160
terminated; "Recruitment problems"
NCT02899702
withdrawn; "no EC approval obtained"
NCT02956122
terminated; "The decision to discontinue the study was based on business reasons."
NCT03202524
withdrawn; "Study was never approved by the IRB"
NCT04048707
withdrawn; "Funding issues; the study was never started"
NCT04071041
terminated; "Low recruitment"
NCT04109144
withdrawn; "PI confirmed that while coordination and planning was conducted upon IRB approval, no participants were enrolled into the study"
NCT04138485
withdrawn; "Due to business reasons, not safety issues"
NCT04216784
terminated; "The study halted prematurely due to staffing."
NCT04450654
withdrawn; "No Participants Enrolled"
NCT04467151
withdrawn; "Did not obtain funding to proceed with study"
recorded 2026-09-01 · last checked 2026-09-04
Q4
Human studies of Albumin used 5% albumin — over how long?
Human studies of Albumin used "5% albumin". ClinicalTrials.gov · 2026-09-01
15 recorded entries; human; intravenously; also "Albumin (5% serum-protein solution containing immunoglobulins)", "Human Albumin 5% CSL Behring", "BUMINATE 25%, Albumin (Human)"
Show the evidence
human
NCT00464126
5% albumin
NCT00708747
Albumin (5% serum-protein solution containing immunoglobulins)
NCT00722475
Human Albumin 5% CSL Behring
NCT00990509
BUMINATE 25%, Albumin (Human)
NCT01206582
Albumin (Human) 25% Solution manufactured by CSL Behring.
NCT01822600
Human Albumin 20%®, ZLB Behring, Marburg, Germany
9 more recorded rows
humanNCT01849757
Albumin 5%
humanNCT01849757
Albumin 25%
humanNCT02270723
5% Human Albumin " Behring"
humanNCT02479802
Human Albumin 5%
humanNCT02673931
20% Human Albumin
humanNCT03167645
Human-Albumin 20 % Behring, salzarm
humanNCT03394508
ALK diluent 0,3% human albumin
humanNCT04522635
(100 ml of Albumin 25%)
humanNCT06629116
intravenously; Patients with AIS receive intravascular therapy, and within 10 minutes after the surgery, they are administered 100ml of 20% human albumin intravenously (infused within 30 minutes).
recorded 2026-09-01 · last checked 2026-09-04
Q5
Which 47 trials of Albumin posted no result?
Posted no result
47 of 47 completed trials
Registrations
NCT00708747, NCT00124228, NCT00464126, NCT01243528, NCT00327704 and NCT01822600, and 41 more
Completion dates
oldest 2003-09; newest 2024-04-18
Show the evidence
Trial
NCT00708747
2003-09
NCT00124228
2008-10
NCT00464126
2009-07
NCT01243528
2010-12
NCT00327704
2011-01
NCT01822600
2011-08
14 further recorded trials
NCT01758172
2012-01
NCT00886925
2012-07
NCT02878733
2013-03
NCT01559519
2013-12
NCT00968695
2014-04
NCT00722475
2014-05
NCT01124981
2014-12
NCT02756741
2015-07
NCT00839358
2016-02
NCT02738190
2016-05
NCT02467322
2016-12-15
NCT02467348
2017-01-31
NCT02468089
2017-08-31
NCT02613052
2017-09
Q6
At the median, Albumin's trials enrolled 70 people — anything larger?
Median enrolment
70
Largest enrolment
10000
Registered trials counted
127
Q7
What do 397 spontaneous reports say about Albumin — and not say?
These are reports people sent to a regulator. They do not show the medicine caused the reaction. Nobody counted how many people took the medicine and reported nothing. The same event can be reported more than once, and many reports are incomplete. News coverage, lawsuits and new warnings change how often people report. A count is not a rate and not a risk.
Albumin appears in spontaneous reports to regulators. Across the 10 most-reported reaction terms, 397 reaction mentions were counted: hypotension 62; acute kidney injury 54; premature baby 49; dyspnoea 42. FAERS via Open Targets · CHEMBL1201451 · 2026-06-24
ALBUMIN HUMAN, Albumin, blood, Albumin bovine, Albumin human. plasma-derived, Albumin microspheres, human, Albumin. plasma-derived, Albumin test, Albumisol, Albutein, Allergen: bos d 6, Bovine albumin, Bovine serum albumin
Trade name
Albuminar-5, Albumin human component of abi-009, Buminate, Plasbumin, Albuked, Flexbumin, Albuminex, Alburx, Albutein / Plasbumin / Albuked / Flexbumin / Albuminex / Alburx
ChEMBL 37 — CC BY-SA 3.0 Unported · ChEMBL ATC CC BY-SA · ClinicalTrials.gov — US Government work · Open Targets 26.06 — CC0 · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md · openFDA / DailyMed — US Government work
✗ required summary fields resolved: 4 required field(s) not terminal: Why people use it, Best-supported result, Biggest unanswered question, Human evidence
✓ public claims reviewed: 0 reviewed claim(s); drafts are never rendered
✓ source coverage passed: 6 source rows
✓ no critical contamination: no quarantine open
✓ canonical metadata passed: slug and display name present
✓ no raw internal fields: enforced by the copy-contract test over the rendered page
This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.